Intercept Pharma Brings On Immunomedics GC As Top Atty
The top lawyer at the drug development firm Immunomedics has left for a general counsel spot at liver disease-focused Intercept Pharmaceuticals Inc. following Immunomedics' $21 billion sale to Gilead Sciences last...To view the full article, register now.
Already a subscriber? Click here to view full article